Combination Therapy of Gefitinib and MiR-30a-5p May Overcome the Acquired Drug Resistance by Regulating PI3K/AKT Pathway in Non-Small Cell Lung Cancer
Keyword(s):
2020 ◽
2015 ◽
Vol 75
(22)
◽
pp. 4937-4948
◽
Keyword(s):
2018 ◽
Keyword(s):
Keyword(s):
FGFRL1 affects chemoresistance of small‐cell lung cancer by modulating the PI3K/Akt pathway via ENO1
2020 ◽
Vol 24
(3)
◽
pp. 2123-2134
◽
Keyword(s):
2021 ◽
Vol 567
◽
pp. 79-85
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):